The authors conclude, "improvements in trial initiation should encourage potential partners in the pharmaceutical and biotechnology industries to view the NCI's publicly funded clinical trials system ...
Using Indirect Comparisons of Prospective, Randomized Trials to Make Therapeutic Decisions in Melanoma: Cross-Trial Comparisons as Surrogates for Proper Head-To-Head Studies? Clinical trials are ...
The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...
The Alliance for Clinical Trials in Oncology is a national leader in advancing cancer research, uniting more than 25,000 ...
The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...
MADRID, Spain and CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop ...
Patient Engagement With Clinicians and Family Members About Genetic Test Results Across Risk Groups in Women With Hereditary Cancer Susceptibility Cooperative group cancer clinical trials have long ...
NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...
Charles Peyton, M.D. associate professor in the UAB Department of Urology, has been selected as a recipient of the highly competitive 2025 NCI Early Career Cancer Clinical Investigator Award (ECIA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results